Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 9, 2013 - Issue 4
Submit an article Journal homepage
1,466
Views
58
CrossRef citations to date
0
Altmetric
Reviews

Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

Hugh A BartonPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
,
Yurong LaiPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
,
Theunis C GoosenPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
,
Hannah M JonesPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Cambridge, MA 02140, USA
,
Ayman F El-KattanPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
,
James R GossetPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Cambridge, MA 02140, USA
,
Jian LinPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
&
Manthena V VarmaPfizer Worldwide Research and Development, Department of Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT 06340, USA+1 860 715 0257; [email protected]
, PhD show all
Pages 459-472 | Published online: 21 Jan 2013

Citations (58)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Irene Hernández Lozano & Oliver Langer. (2020) Use of imaging to assess the activity of hepatic transporters. Expert Opinion on Drug Metabolism & Toxicology 16:2, pages 149-164.
Read now
Mohd Yaseen Malik, Swati Jaiswal, Abhisheak Sharma, Mahendra Shukla & Jawahar Lal. (2016) Role of enterohepatic recirculation in drug disposition: cooperation and complications. Drug Metabolism Reviews 48:2, pages 281-327.
Read now
Bo Feng, Manthena V Varma, Chester Costales, Hui Zhang & Larry Tremaine. (2014) In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery. Expert Opinion on Drug Discovery 9:8, pages 873-890.
Read now

Articles from other publishers (55)

Leslie Z. Benet & Jasleen K. Sodhi. (2023) The Uses and Advantages of Kirchhoff’s Laws vs. Differential Equations in Pharmacology, Pharmacokinetics, and (Even) Chemistry. The AAPS Journal 25:3.
Crossref
Jonathan Asher Pachter, Ken A. Dill, Jasleen K. Sodhi & Leslie Z. Benet. (2022) Review of the application of Kirchhoff's Laws of series and parallel flows to pharmacology: Defining organ clearance. Pharmacology & Therapeutics 239, pages 108278.
Crossref
Eleanor Jing Yi Cheong, Daniel Zhi Wei Ng, Sheng Yuan Chin, Ziteng Wang & Eric Chun Yong Chan. (2022) Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug–drug–disease interactions with protein kinase inhibitors in cancer‐associated venous thromboembolism. British Journal of Clinical Pharmacology 88:5, pages 2267-2283.
Crossref
Qian Yang & Albert P. Li. (2021) Messenger RNA Expression of Albumin, Transferrin, Transthyretin, Asialoglycoprotein Receptor, Cytochrome P450 Isoform, Uptake Transporter, and Efflux Transporter Genes as a Function of Culture Duration in Prolonged Cultured Cryopreserved Human Hepatocytes as Collagen-Matrigel Sandwich Cultures: Evidence for Redifferentiation upon Prolonged Culturing. Drug Metabolism and Disposition 49:9, pages 790-802.
Crossref
Patrick Poulin & Sami Haddad. (2021) A New Guidance for the Prediction of Hepatic Clearance in the Early Drug Discovery and Development from the in Vitro-to-in Vivo Extrapolation Method and an Approach for Exploring Whether an Albumin-Mediated Hepatic Uptake Phenomenon Could be Present Under in Vivo Conditions. Journal of Pharmaceutical Sciences 110:7, pages 2841-2858.
Crossref
Yaru Peng, Zeneng Cheng & Feifan Xie. (2021) Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches. Metabolites 11:2, pages 75.
Crossref
Xiaomin Liang, Yeojin Park, Natalie DeForest, Jia Hao, Xiaofeng Zhao, Congrong Niu, Kelly Wang, Bill Smith & Yurong Lai. (2020) In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation. Drug Metabolism and Disposition 48:12, pages 1283-1292.
Crossref
K. Darney, L. Turco, F.M. Buratti, E. Di Consiglio, S. Vichi, A.C. Roudot, C. Béchaux, E. Testai, J.L.C.M. Dorne & L.S. Lautz. (2020) Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment. Food and Chemical Toxicology 140, pages 111305.
Crossref
Jasleen K. Sodhi, Shuaibing Liu & Leslie Z. Benet. (2020) Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kpuu) on Prediction of Drug-Drug Interactions. Pharmaceutical Research 37:4.
Crossref
Rob C. van Wijk, Rami Ayoun Alsoud, Hans Lennernäs & Ulrika S. H. Simonsson. (2020) Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations. Applied Sciences 10:7, pages 2376.
Crossref
Emi Kimoto, R. Scott Obach & Manthena V.S. Varma. (2020) Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions. Drug Metabolism and Pharmacokinetics 35:1, pages 18-29.
Crossref
Ravindra Varma Alluri & Manthena V.S. Varma. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 609 631 .
Leslie Z. Benet, Christine M. Bowman & Jasleen K. Sodhi. (2019) How Transporters Have Changed Basic Pharmacokinetic Understanding. The AAPS Journal 21:6.
Crossref
Leslie Z. Benet, Christine M. Bowman, Shufang Liu & Jasleen K. Sodhi. (2018) The Extended Clearance Concept Following Oral and Intravenous Dosing: Theory and Critical Analyses. Pharmaceutical Research 35:12.
Crossref
Pedro Caetano-Pinto & Simone H. Stahl. (2018) Perspective on the Application of Microphysiological Systems to Drug Transporter Studies. Drug Metabolism and Disposition 46:11, pages 1647-1657.
Crossref
Nicole A. Kratochwil, Miriam Triyatni, Martina B. Mueller, Florian Klammers, Brian Leonard, Dan Turley, Josephine Schmaler, Aynur Ekiciler, Birgit Molitor, Isabelle Walter, Pierre-Alexis Gonsard, Charles A. Tournillac, Alexandre Durrwell, Michaela Marschmann, Russell Jones, Mohammed Ullah, Franziska Boess, Giorgio Ottaviani, Yuyan Jin, Neil J. Parrott & Stephen Fowler. (2018) Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor. Journal of Pharmacology and Experimental Therapeutics 365:2, pages 237-248.
Crossref
Kathleen M. Giacomini & Huan-Chieh Chien. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants 15 24 .
Karol Jaroch, Alina Jaroch & Barbara Bojko. (2018) Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment. Journal of Pharmaceutical and Biomedical Analysis 147, pages 297-312.
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment 309 329 .
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment 77 138 .
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment 387 430 .
Yongkai Sun, Paresh P. Chothe, Jennifer E. Sager, Hong Tsao, Amanda Moore, Leena Laitinen & Niresh Hariparsad. (2017) Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction Predictions. Drug Metabolism and Disposition 45:6, pages 692-705.
Crossref
Mariline Gameiro, Renata Silva, Carolina Rocha-Pereira, Helena Carmo, Félix Carvalho, Maria Bastos & Fernando Remião. (2017) Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP. Molecules 22:4, pages 600.
Crossref
A Chhibber, C E French, S W Yee, E R Gamazon, E Theusch, X Qin, A Webb, A C Papp, A Wang, C Q Simmons, A Konkashbaev, A S Chaudhry, K Mitchel, D Stryke, T E Ferrin, S T Weiss, D L Kroetz, W Sadee, D A Nickerson, R M Krauss, A L George, E G Schuetz, M W Medina, N J Cox, S E Scherer, K M Giacomini & S E Brenner. (2016) Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. The Pharmacogenomics Journal 17:2, pages 137-145.
Crossref
MV Varma, E Kimoto, R Scialis, Y Bi, J Lin, H Eng, AS Kalgutkar, AF El-Kattan, AD Rodrigues & LM Tremaine. (2017) Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. Clinical Pharmacology & Therapeutics 101:3, pages 406-415.
Crossref
Vikram Arya & Jennifer J. Kiser. (2016) Role of Transporters in Drug Development. The Journal of Clinical Pharmacology 56, pages S7-S10.
Crossref
Yuzhuo Pan, Vicky Hsu, Manuela Grimstein, Lei Zhang, Vikram Arya, Vikram Sinha, Joseph A. Grillo & Ping Zhao. (2016) The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives. The Journal of Clinical Pharmacology 56, pages S122-S131.
Crossref
Houfu Liu & Jasminder Sahi. (2016) Role of Hepatic Drug Transporters in Drug Development. The Journal of Clinical Pharmacology 56, pages S11-S22.
Crossref
Manthena V. Varma & Ayman F. El-Kattan. (2016) Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models. The Journal of Clinical Pharmacology 56, pages S99-S109.
Crossref
William Brian, Larry M Tremaine, Million Arefayene, Ruben de Kanter, Raymond Evers, Yingying Guo, James Kalabus, Wen Lin, Cho-Ming Loi & Guangqing Xiao. (2016) Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Pharmacogenomics 17:6, pages 615-631.
Crossref
Q. Li, H. Yang, D. Guo, T. Zhang, J. E. Polli, H. Zhou & Y. Shu. (2016) Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects. Drug Metabolism and Disposition 44:4, pages 489-494.
Crossref
Tom De Bruyn, Patrick F. Augustijns & Pieter P. Annaert. (2016) Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat. Journal of Pharmaceutical Sciences 105:2, pages 846-853.
Crossref
James S. Brodie, Vincenzo Di Marzo & Geoffrey W. Guy. (2015) Polypharmacology Shakes Hands with Complex Aetiopathology. Trends in Pharmacological Sciences 36:12, pages 802-821.
Crossref
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Hugh A. Barton, Harvey J. Clewell & Miyoung Yoon. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics 359 390 .
Karen Rowland-Yeo & Geoffrey T. Tucker. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics 283 308 .
Jennifer E. Sager, Jingjing Yu, Isabelle Ragueneau-Majlessi & Nina Isoherranen. (2015) Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification. Drug Metabolism and Disposition 43:11, pages 1823-1837.
Crossref
Manthena V. S. Varma, Jian Lin, Yi-an Bi, Emi Kimoto & A. David Rodrigues. (2015) Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1- O - β -Glucuronide . Drug Metabolism and Disposition 43:7, pages 1108-1118.
Crossref
Albert P. Li. (2015) Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOC TM ) System . Toxicological Research 31:2, pages 137-149.
Crossref
Manthena V. Varma, K. Sandy Pang, Nina Isoherranen & Ping Zhao. (2015) Dealing with the complex drug-drug interactions: Towards mechanistic models. Biopharmaceutics & Drug Disposition 36:2, pages 71-92.
Crossref
R Li, H A Barton & T S Maurer. (2014) Toward Prospective Prediction of Pharmacokinetics in OATP1B1 Genetic Variant Populations. CPT: Pharmacometrics & Systems Pharmacology 3:12, pages 1-9.
Crossref
Manthena V. Varma, Yi-an Bi, Emi Kimoto & Jian Lin. (2014) Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model. Journal of Pharmacology and Experimental Therapeutics 351:1, pages 214-223.
Crossref
Rui Li, Hugh A. Barton & Manthena V. Varma. (2014) Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved. Clinical Pharmacokinetics 53:8, pages 659-678.
Crossref
Manthena V. S. Varma, Renato J. Scialis, Jian Lin, Yi-An Bi, Charles J. Rotter, Theunis C. Goosen & Xin Yang. (2014) Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide. The AAPS Journal 16:4, pages 736-748.
Crossref
Albert P Li. (2014) Biomarkers and human hepatocytes. Biomarkers in Medicine 8:2, pages 173-183.
Crossref
Nathan D. PfeiferRhiannon N. HardwickKim L.R. Brouwer. (2014) Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics. Annual Review of Pharmacology and Toxicology 54:1, pages 509-535.
Crossref
M. Jamei, F. Bajot, S. Neuhoff, Z. Barter, J. Yang, A. Rostami-Hodjegan & K. Rowland-Yeo. (2013) A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine. Clinical Pharmacokinetics 53:1, pages 73-87.
Crossref
Tristan M. Sissung, Andrew K. L. Goey, Ariel M. Ley, Jonathan D. Strope & William D. Figg. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 91 120 .
Li Di, Bo Feng, Theunis C. Goosen, Yurong Lai, Stefanus J. Steyn, Manthena V. Varma & R. Scott Obach. (2013) A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development. Drug Metabolism and Disposition 41:12, pages 1975-1993.
Crossref
Chiho OnoHironori Kikkawa, Akiyuki Suzuki, Misaki Suzuki, Yuichi Yamamoto, Katsuomi Ichikawa, Masato Fukae & Ichiro Ieiri. (2013) Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions. Pharmacogenomics 14:14, pages 1745-1764.
Crossref
Yi‐an Bi, Xi Qiu, Charles J. Rotter, Emi Kimoto, Mary Piotrowski, Manthena V. Varma, Ayman F. EI‐Kattan & Yurong Lai. (2013) Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin. Biopharmaceutics & Drug Disposition 34:8, pages 452-461.
Crossref
Manthena V. S. Varma, Jian Lin, Yi-An Bi, Charles J. Rotter, Odette A. Fahmi, Justine L. Lam, Ayman F. El-Kattan, Theunis C. Goosen & Yurong Lai. (2013) Quantitative Prediction of Repaglinide-Rifampicin Complex Drug Interactions Using Dynamic and Static Mechanistic Models: Delineating Differential CYP3A4 Induction and OATP1B1 Inhibition Potential of Rifampicin. Drug Metabolism and Disposition 41:5, pages 966-974.
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development 675 718 .
Kazuya Maeda & Yuichi Sugiyama. 2013. Transporters in Drug Development. Transporters in Drug Development 121 153 .
Jonathan Asher Pachter, Ken A. Dill, Jasleen K. Sodhi & Leslie Z. Benet. (2022) Review of the First Recognized Application of Kirchhoff's Laws to Pharmacology: Defining Organ Clearance. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.